診斷影像市場研究

The medical and diagnostic imaging industry is poised to see continued growth in the years ahead as an aging population will increasingly need these important services. Enhanced access to health insurance for many Americans will also improve access to these services.

Diagnostic imaging is a big business worldwide, generating billions in revenue.  Diagnostic Market Research provides insight into market opportunities and positioning.

MRI’s, Ultrasounds, Elastography, and Thermology are becoming increasingly familiar to patients as these sought-after services provide tangible and beneficial medical results.  SIS國際研究 assists companies and new entrants in understanding the markets they are already in, and those they wish to penetrate.

We provide cutting-edge data, market insights, competitive intelligence services, and expert analysis that provide actionable insight for decision making.

Diagnostic Imaging Market Research: How Leading Manufacturers Win Share

Diagnostic imaging market research separates manufacturers building durable share from those competing on specs alone. The category rewards firms that read radiologist workflow, hospital capital budgets, and reimbursement shifts before the curve forms. The opportunity sits in the intelligence layer beneath the technology.

Capital equipment cycles in MRI, CT, ultrasound, PET, and digital radiography have lengthened. Hospital systems consolidate purchasing through integrated delivery networks. Reimbursement codes shift. Reading volumes migrate to teleradiology platforms. Each of these forces changes how a buying decision is actually made, and most product roadmaps still respond to the previous decade’s evidence.

What Diagnostic Imaging Market Research Reveals That Spec Sheets Miss

The conventional approach benchmarks competitors on slice count, Tesla rating, detector resolution, and list price. The better approach maps the buying committee. A modality purchase at a 600-bed academic medical center involves the chief of radiology, the imaging service line administrator, biomedical engineering, supply chain, the CFO, and increasingly the CIO. Each weights the decision differently.

Diagnostic imaging market research that ignores this structure produces clean reports and stalled tenders. Research that maps it produces win rates. The shift from departmental purchasing to enterprise capital planning has compressed vendor influence at the radiologist level and elevated total cost of ownership analysis at the executive level. Installed base analytics, service contract economics, and uptime guarantees now decide more deals than image quality demonstrations.

The Modalities Where Growth Is Concentrated

Growth is uneven across the imaging portfolio. Demand patterns reward specific positioning rather than broad coverage.

• Point-of-care ultrasound (POCUS): Handheld and cart-based units expand into emergency medicine, anesthesia, and primary care. Buyers are clinicians, not radiology departments. The sales motion is different.
• AI-enabled CT and MRI: GE HealthCare, Siemens Healthineers, Philips, and Canon Medical compete on embedded reconstruction algorithms and triage software. The differentiator is regulatory clearance breadth, not raw computing.
• Photon-counting CT: A premium tier where early-adopter academic centers shape reference site narratives that drive community hospital decisions for the following five years.
• Mobile and refurbished imaging: A pricing-sensitive segment growing in ambulatory surgery centers, rural systems, and emerging markets. Margins are thinner. Volume is real.

A bill of materials optimization exercise across these modalities reveals how component sourcing, particularly detectors, gradient coils, and helium supply for MRI, drives margin variance more than feature differentiation.

How the Best Manufacturers Use Primary Research

According to SIS International Research, structured B2B expert interviews with radiologists, imaging directors, and procurement leads consistently surface a gap between what hospitals state in RFPs and what actually drives the award decision. Service responsiveness, training depth, and PACS interoperability outweigh stated price thresholds in roughly two-thirds of competitive evaluations across academic and community hospital segments in North America, Latin America, and Western Europe.

SIS International’s competitive intelligence work in diagnostic testing markets across Brazil and Mexico, including PPD, PCR, IGRA, and GeneXpert evaluations, demonstrates how reimbursement structure and public-versus-private channel dynamics dictate adoption pace far more than clinical performance data alone. The same pattern holds in imaging modalities.

The methodologies that produce decision-grade evidence include voice of customer programs across radiologist and technologist panels, ethnographic observation in reading rooms, win/loss analysis on completed tenders, and competitive intelligence on installed base and service contract pricing. Survey-only studies miss the workflow signal.

The Reimbursement and Regulatory Currents Reshaping Demand

CMS code adjustments in the United States, the EU Medical Device Regulation, China’s Volume-Based Procurement program, and ANVISA’s evolving registration pathway in Brazil each change the math on a modality launch. Manufacturers tracking these as legal matters miss the commercial signal. Tracked as demand drivers, they predict where unit volumes will compress and where new white space opens.

Photon-counting CT reimbursement coding, AI software billing under new CPT categories, and theranostic imaging tied to radiopharmaceutical pipelines are three current examples where reimbursement clarity will determine adoption velocity through the late 2020s.

A Practitioner Framework for Imaging Intelligence

The SIS Imaging Decision Map organizes intelligence around the four signals that move share:

Source: SIS International Research

Manufacturers running this framework quarterly outperform those commissioning ad hoc studies tied to product launches.

Where Diagnostic Imaging Market Research Creates Asymmetric Advantage

Three areas reward early intelligence investment.

Emerging market entry. Brazil, Mexico, India, Indonesia, and the Gulf states each present different reimbursement architectures, distributor structures, and refurbished equipment competition. SIS International’s market entry assessments across Latin American healthcare markets show that distributor selection and post-sale service infrastructure predict five-year market share more reliably than initial product positioning.

AI software monetization. The shift from one-time license to subscription and per-study pricing changes how hospitals account for the spend. Buyers compare AI offerings against radiologist productivity gains, not against each other. Research that quantifies the productivity delta wins the renewal.

Aftermarket and service revenue. Service contracts represent the highest-margin revenue in the imaging portfolio for most OEMs. Independent service organizations have grown share. Intelligence on customer satisfaction, contract renewal triggers, and parts pricing transparency protects this revenue line.

The Intelligence Layer That Separates Leaders

Diagnostic imaging market research delivers value when it answers the questions a leadership team cannot answer from internal data: how the buying committee actually decides, which competitor service model is winning renewals, where reimbursement will accelerate adoption, and which emerging modality crosses from academic novelty to community standard. Public reports cannot answer these. Custom primary research can.

The manufacturers building durable share treat market research as a recurring intelligence function tied to specific decisions, not as a launch deliverable. The discipline compounds.

關於 SIS 國際

SIS國際 提供定量、定性和策略研究。我們為決策提供數據、工具、策略、報告和見解。我們也進行訪談、調查、焦點小組和其他市場研究方法和途徑。 聯絡我們 為您的下一個市場研究項目。